Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameArrail Group
Stock Code06639
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities中國領先的口腔醫療服務集團,運營瑞爾齒科(高端)和瑞泰口腔(中端)品牌,提供普通牙科、正畸科及種植科等專業及個性化口腔醫療服務。
Listing Date2022-03-22
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市朝陽區朝來高科技產業園紫月路18號院11號樓6層
Business Address (Hong Kong)香港灣仔皇后大道東248號大新金融中心40樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.arrailgroup.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 14.62 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 7,310
Par ValueTo be extracted
Offer Period2022-03-09 to 2022-03-14
Global Offering Shares46,527,500 shares
HK Public Offer Shares (Initial)4,653,000 shares (10.0%)
Public Offer Lots (Initial)9,306lots (Pool A4,653lots,Pool B4,653lots)
International Placing Shares (Initial)41,874,500 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO581,591,950 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share74.7%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 680,232,050

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 7,310
2 lots 1,000 HK$ 14,620
3 lots 1,500 HK$ 21,930
4 lots 2,000 HK$ 29,240
5 lots 2,500 HK$ 36,550
6 lots 3,000 HK$ 43,860
7 lots 3,500 HK$ 51,170
8 lots 4,000 HK$ 58,480
9 lots 4,500 HK$ 65,790
10 lots 5,000 HK$ 73,100
12 lots 6,000 HK$ 87,720
14 lots 7,000 HK$ 102,340
16 lots 8,000 HK$ 116,960
18 lots 9,000 HK$ 131,580
20 lots 10,000 HK$ 146,200
30 lots 15,000 HK$ 219,300
40 lots 20,000 HK$ 292,400
50 lots 25,000 HK$ 365,500
60 lots 30,000 HK$ 438,600
70 lots 35,000 HK$ 511,700
90 lots 45,000 HK$ 657,900
100 lots 50,000 HK$ 731,000
120 lots 60,000 HK$ 877,200
140 lots 70,000 HK$ 1,023,400
160 lots 80,000 HK$ 1,169,600
180 lots 90,000 HK$ 1,315,800
200 lots 100,000 HK$ 1,462,000
400 lots 200,000 HK$ 2,924,000
600 lots 300,000 HK$ 4,386,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
800 lots 400,000 HK$ 5,848,000
1,400 lots 700,000 HK$ 10,234,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 1.03B
Est. Threshold HK$ 9.73B
Analysis Result HK market cap below threshold, need +846%

Valuation & Financials

Market Cap (at Offer Price)HK$ 8,502,874,309
Pre-IPO Valuation (Last Round)Not disclosed
P/E Ratio不適用(公司處於虧損狀態)
Profit/Loss Status虧損人民幣597.8百萬元
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 90,332,050
Listing Expenses / Funds Raised~13.28%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 2019-032020-032021-03
Revenue 1,080,2911,099,8681,515,127
Cost of sales -916,519-988,477-1,150,707
Gross profit 163,772111,391364,420
Other income and gains, net -4,468-3,1292,286
Selling and distribution expenses -105,576-84,825-79,122
Administrative expenses -103,878-112,680-130,330
Operating profit -84,043-133,444124,467
Net finance costs -28,662-38,685-44,333
Share of associates and JVs -9,939-2,7162,602
Profit before tax -315,462-320,894-581,744
Income tax expense 11,293-4,931-16,018
Profit for the year -304,169-325,825-597,762
Profit attributable to owners -301,178-316,854-599,420
Balance Sheet
Item 2019-032020-032021-032021-09
Cash and cash equivalents 168,457172,618676,304
Trade and bills receivables 111,745105,017155,935
Inventories 38,45537,50039,036
Total current assets 586,785620,1181,092,961
Total assets 1,875,7361,902,9912,350,754
Total current liabilities 740,2903,370,3644,257,453
Total liabilities 3,512,2693,931,0944,807,331
Total equity -1,636,533-2,028,103-2,456,577
Equity attributable to owners -1,678,334-2,064,767-2,499,872
Interest-bearing borrowings 446,968520,870489,291514,384
Cash Flow Statement
Item 2019-032020-032021-032021-09
Net cash from operating activities 136,809154,294242,870
Net cash from investing activities -309,309-109,59461,753
Net cash from financing activities 34,444-43,847217,513
Net increase in cash -138,056853522,136
Purchase of PP&E -184,020-289,110-1,134,830-40,150
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 13.8
First Day OpenHK$ 14.6
First Day Change-5.61%
First Day Volume6072000.0
First Day Turnover84333900.0
Use of Proceeds
1、約75%(或442.4百萬港元)將用于業務擴張、在現有及新城市開設新的瑞爾齒科和瑞泰口腔的醫院及診所; 2、約15%(或88.5百萬港元)將用于建設及優化我們的信息技術基礎設施; 3、約10%(或59.0百萬港元)將用作營運資金,以繼續為客戶提供優質的口腔醫療服務,通過采取以下舉措。

Underwriting Syndicate

Joint Sponsors (2)
Morgan Stanley Asia Limited CE AAD291 UBS Securities Hong Kong Limited CE BIN466
Overall Coordinators (4)
Morgan Stanley Asia Limited CE AAD291 UBS Securities Hong Kong Limited CE BIN466 CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 海通国际证券有限公司 CE AAF806
Joint Bookrunners (7)
Morgan Stanley Asia Limited CE AAD291 UBS Securities Hong Kong Limited CE BIN466 CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 海通国际证券有限公司 CE AAF806 香港上海汇丰银行有限公司 CE AAA523 富途证券国际(香港)有限公司 CE AZT137 招银国际融资有限公司 CE AVM940
Joint Lead Managers (7)
Morgan Stanley Asia Limited CE AAD291 UBS Securities Hong Kong Limited CE BIN466 CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 海通国际证券有限公司 CE AAF806 香港上海汇丰银行有限公司 CE AAA523 富途证券国际(香港)有限公司 CE AZT137 招银国际融资有限公司 CE AVM940

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Abax Asian Structured Private Credit Fund III, LP 195,330,510 HKD — 28.72% — 6 months 2022-09-22
2 Harvest International Premium Value (Secondary Market) Fund SPC 156,258,560 HKD — 22.97% — 6 months 2022-09-22
3 Hudson Bay Master Fund LTD 78,129,280 HKD — 11.49% — 6 months 2022-09-22
4 OrbiMed Funds 39,064,640 HKD — 5.74% — 6 months 2022-09-22
5 高鹏(香港)有限公司 39,064,640 HKD — 5.74% — 6 months 2022-09-22

Directors & Management

PositionChinese nameEnglish Name
Chairman鄒其芳—
Company Secretary王承鏱—
No director data available.

Major Shareholders

Major Shareholders & Holdings鄒其芳先生透過Rise Day Holdings Limited、Mingda International Limited、Beier Holdings Limited及ESOP BVI持有本公司約31.55%權益,為控股股東;其他主要股東包括Elbrus Investments Pte. Ltd.(10.01%)、Total Success Investment Ltd.(9.50%)、Broad Street Investments Holding (Singapore) Pte. Ltd.(6.31%)、KPCB China Fund, L.P.(5.40%)、HH AGL Holdings Limited(4.72%)等。
About this page

This page shows Arrail Group (06639) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect